As we approach the semi-annual review of the global innovation landscape, we are currently engaged in highly concentrated expert discussions with the members of the Singularity Think Tank. Our Director of Research, Shiko Ben-Menahem, PhD, delves into the reasons why AI in drug discovery and development has yet to make an impact. He also explores the potential of sequencing technologies in revolutionizing the field of diagnostics.

By - 09/26/2023